Atlas Trials

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

Clinical trial NCT07734844 · RECRUITING

Trial details

NCT number
NCT07734844
Sponsor
Kodiak Sciences Inc
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Macular Edema (DME)
Start date
2026-08-03
Primary completion
2028-08-31
Enrollment
910

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.